ADA Scientific Sessions 2026 Abstract·6 JunEfficacy and Safety of a Novel Oral Small Molecule Glucagon-Like Peptide 1 Receptor Agonist (HDM1002) in Type 2 Diabetes Mellitus Patients Inadequately Controlled on Diet and Exercise or MetforminTrial in peopleInterventionsPaper